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Abstract
Background and Objectives
Acute kidney injury (AKI) necessitating renal replacement therapy (RRT) is associated with
high mortality and increased risk for end stage renal disease. However, it is unknown if this
applies to patients with a preliminary unremarkable medical history. The purpose of this
study was to describe overall and renal survival in critically ill patients with AKI necessitating
RRT stratified by the presence of comorbidity.
Design, Setting, Participants, and Measurements
A retrospective cohort study was performed, between 1994 and 2010, including all adult crit-
ically ill patients with AKI necessitating RRT, stratified by the presence of comorbidity. Lo-
gistic regression, survival curve and cox proportional hazards analyses were used to
evaluate overall and renal survival. Standardized mortality rate (SMR) analysis was per-
formed to compare long-term survival to the predicted survival in the Dutch population.
Results
Of the 1067 patients included only 96(9.0%) had no comorbidity. Hospital mortality was
56.6% versus 43.8% in patients with and without comorbidity, respectively. In those who
survived hospitalization 10-year survival was 45.0% and 86.0%, respectively. Adjusted for
age, sex and year of treatment, absence of comorbidity was not associated with hospital
mortality (OR=0.74, 95%-CI=0.47-1.15), while absence of comorbidity was associated with
better long-term survival (adjusted HR=0.28, 95%-CI = 0.14-0.58). Compared to the Dutch
population, patients without comorbidity had a similar mortality risk (SMR=1.6, 95%-CI=0.7-
3.2), while this was increased in patients with comorbidity (SMR=4.8, 95%-CI=4.1-5.5). Re-
garding chronic dialysis dependency, 10-year renal survival rates were 76.0% and 92.9% in
patients with and without comorbidity, respectively. Absence of comorbidity was associated
with better renal survival (adjusted HR=0.24, 95%-CI=0.07-0.76).
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Conclusions
While hospital mortality remains excessively high, the absence of comorbidity in critically ill
patients with RRT-requiring AKI is associated with a relative good long-term prognosis in
those who survive hospitalization.
Introduction
Despite improvement in medical care, acute kidney injury (AKI) is a major complication in
critically ill patients. Over the past decades a steady increase in incidence of AKI has been re-
ported, while mortality continues to be excessively high [1–5]. The increased incidence of AKI
is likely caused by increasing age, a greater burden of comorbidity, pre-existing chronic kidney
disease (CKD), the greater use of nephrotoxic drugs and iodine-containing contrast for radio-
logical imaging. Today, AKI occurs in approximately 10–67% of those admitted to the inten-
sive care unit (ICU) [6–13] and in 3–8% renal replacement therapy (RRT) is necessary [6,12].
AKI requiring RRT is associated with a hospital mortality rate about 50–60% and survivors
have a substantial risk for end-stage renal disease (ESRD) [3,14–18]. However, an average ICU
population is characterized by the heavy burden of comorbidities, which may substantially in-
fluence both mortality and renal recovery or even the development of AKI itself [19–21]. In re-
cent literature, the impact of comorbid conditions on renal recovery after AKI and the long-
term sequelae is a major topic of discussion [20,22–25]. Given the complex interplay between
AKI and comorbidity, it is difficult to determine the true impact of AKI on ESRD and mortali-
ty, especially in the long-term. Therefore, overestimation of the risk for these outcomes may
occur in subpopulations with lower levels of comorbidity. In particular, in those who are not
burdened by any comorbidity. This study describes overall and renal survival in a group of crit-
ically ill patients with AKI necessitating RRT stratified by the presence of comorbid conditions.
Materials and Methods
Study design and population
A retrospective cohort study was performed including data obtained from patients admitted to
a large tertiary care center (Erasmus Medical Center, Rotterdam, The Netherlands). All critical-
ly ill patients 18 years treated with continuous renal replacement therapy (CRRT) between
January 1994 and April 2010 were evaluated. Patients with RRT or kidney transplant prior to
hospital admission were excluded from analysis. Furthermore, patients in the study population
were categorized by the presence of comorbidity in two groups, patients with (comorbid+) and
patients without comorbidity (comorbid-). When a patient experienced multiple hospital ad-
missions requiring RRT, only the first hospital admission was used for further analysis. The
modalities used for CRRT were continuous arteriovenous haemodialysis (CAVHD) or contin-
uous venovenous haemofiltration (CVVH). Initially, CAVHD was the standard modality for
CRRT, which was later gradually replaced by CVVH. CRRT was prescribed by the attending
nephrologist and delivered by the haemodialysis nursing team. Intermittent haemodialysis was
not performed because most patients in the ICU ward were haemodynamically unstable and
the ICU lacks facilities to perform intermittent haemodialysis. The study was approved by the
medical ethical review board of the Erasmus Medical Center, which waived the requirement
for informed consent, because of its retrospective design.
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Data collection
Data were collected using the hospital electronic patient records (EPR). Detailed clinical and
demographic data were collected for patients without comorbidity including primary cause of
AKI, type of ICU admission, primary indication for ICU admission, CRRT modality, non-
renal SOFA score and number of ICU admission days. Furthermore, at hospital admission, at
start of CRRT and at hospital discharge serum creatinine values were collected. Baseline renal
function was not known in the majority of patients, as they were not under medical care prior
to hospital admission. Given the uncertain relation between serum creatinine concentrations
and renal function at hospital admission and start of CRRT we only calculated the estimated
glomerular filtration rate (eGFR) at hospital discharge. To determine whether a patient reached
ESRD requiring RRT after hospital discharge we used data from the RENINE Foundation. This
foundation manages a Dutch national database containing all patients treated with RRT for at
least 3 months and therefore considered chronically dependent on RRT.
Definitions
The patient records were used to identify whether patients were known with malignancy, solid
organ transplantation, intravenous drug abuse and pre-existing chronic diseases such as CKD,
hypertension, diabetes mellitus, liver failure, cardiovascular diseases, autoimmune diseases,
chronic obstructive pulmonary disease (COPD), connective tissue diseases and chronic infec-
tious diseases like HIV and hepatitis. Patients without one of these conditions were categorized
in the comorbid- group, while patients with one or more of these conditions were categorized in
the comorbid+ group. The primary cause of AKI was categorized as: sepsis, ischemia, drug-
associated and other. Sepsis was defined in accordance to the Surviving Sepsis Campaign Inter-
national Guidelines [26]. Ischemia was defined as AKI due to hypotension and pre-renal kidney
failure. All patients suffering from AKI due to drugs, contrast and other substances that are
nephrotoxic were categorized in the drug-associated group. Patients that experienced an episode
of AKI due to any other cause then aforementioned, consisting rhabdomyolysis and glomerulo-
nephritis were categorized in the “other” group. Indications for ICU admittance were categorized
as: sepsis, postoperative, traumatic injury, intoxication and other. A postoperative ICU indication
was defined as the need for ICU admission for treatment and monitoring due to perioperative
haemodynamic instability. Reasons for surgery included acute pancreatitis, stomach and bowel
perforations, an intra abdominal abscess and a total hip prosthesis. For estimation of the GFR we
used the modified diet in renal diseases (MDRD) formula adjust for age and sex [27].
Study outcomes
Primary study outcomes were overall and renal survival stratified by the presence of comorbid-
ity. Overall survival was divided into hospital mortality and survival after hospital discharge.
Renal survival was defined as the time until the need for chronic RRT. Long-term overall and
renal survival rates were presented at 1, 5 and 10 years after discharge. In addition, long-term
overall survival was compared to the predicted survival in the Dutch population. Secondary,
patients without comorbidity were evaluated for independent predictors associated with hospi-
tal mortality. Due to the low number of events in patients without comorbidity predictors for
overall and renal survival were not evaluated.
Statistical analysis
Continuous parameters were expressed as median and interquartile range. Categorical parame-
ters were expressed as number and percentage. Logistic regression analysis adjusted for age, sex
AKI in Patients without Comorbidity
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and year of treatment was performed to compare hospital mortality in patients with and with-
out comorbidity. In patients without comorbidity, logistic regression analysis was performed to
determine independent predictors for hospital mortality. Parameters with a p-value 0.1 re-
ported by univariable analysis were considered eligible for multivariable analysis. Irrespective
of p-value the variables age, sex and year of treatment were included in multivariable analysis.
Overall and renal survival after hospital discharge stratified by presence of comorbidity was
evaluated by Kaplan-Meier analysis. Log-rank test was used to analyze crude differences pooled
over strata and cox proportional hazards analysis was used to adjust for age, sex and year of
treatment. The standardized mortality ratio (SMR) was calculated by comparing mortality
after hospital discharge with the expected mortality in the general Dutch population. The SMR
is the ratio of observed to expected number of deaths. The expected number of deaths is calcu-
lated by multiplying the total number of years lived by patients in the study population for
each calendar period in each age and sex category by the age and sex specific mortality rates of
the Dutch population for each calendar period. A two-tailed p-value 0.05 was considered sig-
nificant. Analyses were performed using statistical software SPSS, version 20.0 for Mac (SPSS
Inc., an IBM company, Chicago, IL, USA) and GraphPad Prism version 5.0a for Mac (Graph-
Pad Software, La Jolla, CA, USA)
Results
Study population
A total of 1220 patients treated with CRRT during ICU admission were evaluated during the
study period. After exclusion of 153 patients on chronic RRT or with a kidney transplant the
study population included 1067 patients of which 96 (9.0%) had no comorbidity (Fig. 1).
Fig 1. Flowchart of inclusion and hospital mortality stratified by presence of comorbidity. (C)RRT:
(continuous) renal replacement therapy, ICU: intensive care unit, KT: kidney transplant.
doi:10.1371/journal.pone.0121482.g001
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Clinical characteristics of the patients without comorbidity are presented in Table 1. The medi-
an age was 45 years and 55.2% of the patients were of male gender. The most common cause of
AKI was sepsis (58.3%) followed by ischemia (25.0%). In the largest group of patients sepsis
(37.5%) was also the most frequently indication for ICU admission followed by trauma
(31.3%). CAVHD or CVVH were used in 39 (40.6%) and 57 (59.4%) of the patients as modality
for CRRT. The median non-renal SOFA score at ICU admission was 10 points and only avail-
able in 50 patients. The median serum creatine at hospital admission and start of CRRT were
177 and 427 μmol/L, respectively, and the median length of ICU stay was 21 days.
Hospital mortality
In the group without comorbidity 42 (43.8%) patients deceased during hospitalization com-
pared to 550 (56.6%) of those with comorbidity, respectively (P = 0.02). Adjusted for age, sex
and year of treatment, patients without comorbidity had a similar hospital mortality risk
(Odds ratio [OR] = 0.74, 95% confidence interval [CI] = 0.47–1.15). In subgroup analysis on
patients without comorbidity, univariable analysis identified several clinical variables associat-
ed with hospital mortality presented in Table 2. Only serum creatinine at start of CRRT
Table 1. Clinical and demographical characteristics of 96 patients without comorbidity treated with
CRRT in the ICU.
Characteristic
Age in years (interquartile range) 45 (35–60)
Male sex (%) 53 (55.2)
Cause of AKI (%)
Sepsis 56 (58.3)
Ischemia 24 (25.0)
Drug-associated 9 (9.4)
Other 7 (7.3)
Surgical admission (%) 64 (66.7)
Indication for ICU admission (%)
Sepsis 36 (37.5)
Post-operative 12 (12.5)
Intoxication 10 (10.4)
Trauma 30 (31.3)
Other 8 (8.3)
CRRT modality (%)
CAVHD 39 (40.6)
CVVH 57 (59.4)
Non-renal SOFA score (interquartile range)* 10 (8–13)
Serum creatinine in μmol/L (interquartile range)
Hospital admission 177 (94–350)
Start CRRT 427 (298–569)
Days of ICU stay (interquartile range) 21 (11–38)
Categorical variables are expressed as number and percentage; continuous variables are expressed as
median and interquartile range. AKI: acute kidney injury; CAVHD: continuous arteriovenous haemodialysis;
CRRT: continuous renal replacement therapy; CVVH: continuous venovenous hemoﬁltration; ICU:
intensive care unit; SOFA: sequential organ failure assessment
* Score available in 50 cases
doi:10.1371/journal.pone.0121482.t001
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(OR = 0.96, 95%-CI = 0.93–0.99) and length of ICU stay (OR = 0.96, 95%-CI = 0.94–0.99) re-
mained associated with hospital mortality after multivariable logistic regression analysis.
Survival after hospital discharge
In total, 475 patients left the hospital alive of which 54 had no comorbidity. Median follow-up
time was 4.4 years (2.1–8.0). In general, the percentage of survival at 1, 5 and 10 years in those
that survived hospitalization was 87.2%, 64.7% and 50.4%, respectively. Stratified by presence
of comorbidity survival rates were 85.7%, 61.1% and 45.0% compared to 96.3%, 91,6% and
86.0% in patients with and without comorbidity, respectively (Table 3). Survival curves are pre-
sented in Fig. 2 and log-rank test comparing both groups showed a crude significant difference
in survival (p< 0.001). Adjusted for age, sex and year of treatment, patients without comorbid-
ity had a significant better survival rate (Hazard-ratio [HR] = 0.28, 95%-CI = 0.14–0.58). Com-
pared to the predicted survival in the Dutch population patients without comorbidity had a
similar mortality risk (SMR = 1.6, 95%-CI = 0.7–3.2), while this risk was significantly increased
in patients with comorbidity (SMR = 4.8, 95%-CI = 4.1–5.5) (Table 4). A reference curve,
shown in Fig. 2, represents the predicted survival in the Dutch population matched for age, sex
and calendar period to patients without comorbidity.
Renal function and renal survival after hospital discharge
At time of hospital discharge 55 (11.6%) of all patients were dialysis dependent of which 53
(12.6%) and 2 (3.7%) with and without comorbidity, respectively (p = 0.07). Renal survival
rates at 1, 5 and 10 years were, respectively, 85.8%, 82.9% and 76.0% versus 96.3%, 96.3% and
Table 2. Univariable andmultivariable analysis of characteristics associated with hospital mortality in patients without comorbidity.
Univariable Analysis Multivariable Analysis
OR (95%-CI) P-value OR (95%-CI) P-value
Age in years 1.02 (0.99–1.05) 0.13 1.03 (1.00–1.07) 0.08
Male sex 1.37 (0.60–3.09) 0.45 2.46 (0.67–9.02) 0.18
Surgical admission 1.00 (0.43–2.35) 1.00 - -
Indication for ICU admission
Sepsis 1 1
Post-operative 0.50 (0.13–1.96) 0.32 1.11 (0.21–5.85) 0.90
Intoxication 0.43 (0.10–1.93) 0.27 0.49 (0.09–2.73) 0.42
Trauma 1.14 (0.43–3.02) 0.79 3.17 (0.81–12.37) 0.10
Other 0.14 (0.02–1.28) 0.08 0.44 (0.04–5.46) 0.52
CVVH as CRRT modality 0.60 (0.26–1.36) 0.22 - -
Non-renal SOFA score* 1.07 (0.93–1.24) 0.36 - -
Serum creatinine in μmol/L per 10
points
Hospital admission 0.99 (0.97–1.01) 0.40 - -
Start CRRT 0.98 (0.96–1.00) 0.04 0.96 (0.93–0.99) 0.01
Days of ICU stay 0.98 (0.96–0.99) 0.01 0.96 (0.94–0.99) 0.003
Year of treatment 0.96 (0.88–1.04) 0.31 0.94 (0.83–1.05) 0.28
CRRT: continuous renal replacement therapy; CVVH: continuous venovenous hemoﬁltration; ICU: intensive care unit; SOFA: sequential organ
failure assessment
*Score available in 50 cases
doi:10.1371/journal.pone.0121482.t002
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92.9% in patients with and without comorbidity (Table 3). Renal survival curves stratified by
comorbidity are presented in Fig. 3 and log-rank test comparing both groups showed a crude
significant difference in renal survival (p = 0.003). Adjusted for age, sex and year of treatment
patients without comorbidity had a significant better renal survival rate (HR = 0.24, 95%-
CI = 0.07–0.76). At hospital discharge, grouped by eGFR, 28 (51.9%) patients without comor-
bidity had an eGFR 90, 9 (16.7%) an eGFR = 60–89, 9 (16.7%) an eGFR = 30–59, 3 (5.6%) an
eGFR = 15–29 and 5 (9.3%) patients left the hospital with an eGFR< 15 ml/min/1.73m2.
Discussion
To the best of our knowledge this is the first study to describe overall and renal survival in a
group of critically ill patients with AKI necessitating RRT stratified by the presence of
Table 3. Overall and renal survival of patients that survived hospital admission.
Overall survival (%) Renal survival (%)
1 yr 5 yr 10 yr 1 yr 5 yr 10 yr
Comorbid + 85.7 61.1 45.0 85.8 82.9 76.0
Comorbid - 96.3 91.6 86.0 96.3 96.3 92.9
Data are given as percentage of cumulative overall survival and renal survival at 1, 5 and 10 years stratiﬁed by the presence of comorbidity.
doi:10.1371/journal.pone.0121482.t003
Fig 2. Kaplan-Meier curves for overall survival after hospital discharge stratified by comorbidity. The reference curve represents the predicted
survival in the Dutch population matched for age, sex and calendar period to patients without comorbidity.
doi:10.1371/journal.pone.0121482.g002
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comorbid conditions. We demonstrated that patients without comorbidity constitute a minori-
ty of the ICU population, as only 9% of all ICU patients treated with RRT were not burdened
with relevant pre-existing diseases. Although, hospital mortality in this group was still high, the
overall and renal survival after hospital discharge was relatively good with 10-year survival
rates of 86% and 93%, respectively. In particular the fact that we could not identify a difference
in long-term mortality risk compared to the predicted mortality in the Dutch population is
of interest.
Hospital mortality and associated risk factors
In the overall study population the hospital mortality rate was 55.5%, which is in accordance
with the results of previous studies [3]. We demonstrated that patients without comorbidity
Table 4. Standardized mortality ratio analysis in patients that survived hospital admission.
Sex No. in group No. of deaths Person years SMR (95%-CI) P-value
Comorbid + Male 286 133 1441.8 4.3 (3.6–5.6) <0.001
Female 135 59 691.8 6.5 (4.9–8.4) <0.001
Overall 421 192 2133.6 4.8 (4.1–5.5) <0.001
Comorbid - Male 29 6 255.6 1.7 (0.6–3.6) 0.15
Female 25 2 206.9 1.5 (0.2–5.2) 0.40
Overall 54 8 462.4 1.6 (0.7–3.2) 0.10
Fig 3. Kaplan-Meier curves for renal survival stratified by comorbidity. Defined as years after discharge until chronic replacement therapy is initiated,
censored for death.
doi:10.1371/journal.pone.0121482.g003
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had a crude decreased risk for mortality, but contrary to what we expected, no significant dif-
ference was found after adjusting for age, sex and year of treatment. Given the fact that a trend
towards better survival persisted, it is possible that the lack of statistical significance is due to
the small population of patients without comorbidity. For instance, a recent study by Oster-
mann and Chang [28] evaluating a large cohort of patients (n = 1847) treated with RRT in the
ICU, reported that the presence of one or more comorbidities was associated with increased
ICU mortality. In spite of these results the risk for mortality during hospital admission in the
critically ill patient without comorbidity remains excessively high. Multivariable analysis in pa-
tients without comorbidity revealed that serum creatinine at start of CRRT and length of ICU
stay were associated with hospital mortality. Interestingly, a higher serum creatinine at start of
RRT was associated with lower mortality. This finding is in accordance with previous studies,
which demonstrated that an increase in RIFLE criteria was associated with higher mortality
[29,30], while an absolute higher serum creatinine at time of diagnosis of AKI [29] or start of
RRT [31,32] was associated with lower mortality. A hypothetical explanation for this observa-
tion is that low serum creatinine levels at start of RRT reflect poor clinical condition rather
than better renal function as these patients may have had less muscle mass and/or could have
been more fluid overloaded.
Long-term survival after hospitalization
The results on long-term survival presented in the overall study population are in accordance
with the results of previous studies [33–38]. In contrast to hospital survival, we demonstrated
that there was a great difference in survival after hospitalization in favour of those without co-
morbidity (adjusted HR = 0.28). Because this is the first study evaluating long-term mortality
after AKI stratified by presence or absence of comorbidity it is not possible to directly compare
these results to previous studies. Furthermore, studies that reported survival rates after for in-
stance 5 or 10 years are scarce. Two studies that evaluated long-term mortality after AKI re-
quiring RRT reported overall survival rates after 5 years of 15.5 to 35.5%, including those who
died during hospitalization. These results are in accordance to the survival rate of 26.5% in the
group with comorbidity in our study, including those who died during hospitalization. In pa-
tients without comorbidity this was 51.5%. Interestingly, patients without comorbidity had a
similar long-term mortality risk as predicted in the Dutch population. However, a trend to-
wards a higher mortality risk was reported, and the lack of statistical significance could be the
result small study size, which implies that future studies with a larger sample size
are warranted.
Renal survival after hospitalization
At hospital discharge 11.6% of all patients were dependent on RRT, which is about average
compared to results of previous studies that reported a percentage ranging from 0 to 32%
[15,16,33,39,40]. Our result demonstrated that in patients without comorbidity only 3,7% pa-
tients left the hospital dependent on RRT, which is low compared to most of the aforemen-
tioned studies. However, Schiffl et al. reported that none of the 425 critically ill patients
included in their study reached dialysis dependence at hospital discharge [39]. Interestingly,
this is the only study that excluded all patients with a preliminary impaired renal function.
These results suggest that in particular an impaired renal function prior AKI is an important
risk factor for dialysis dependence thereafter. Furthermore, in a previous study of our research
group we found that in the presence of chronic kidney disease no other comorbid condition
was significantly associated with the need for RRT at hospital discharge in patients surviving
AKI requiring RRT [16]. After hospital discharge only one more patient became chronic
AKI in Patients without Comorbidity
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dialysis dependent after 7.5 years of follow-up. This 33-year-old male patient was admitted
to the ICU after a severe trauma (motor accident) and left the hospital with an eGFR of
28 ml/min/1.73m², which slowly decreased towards ESRD necessitating dialysis. An explana-
tion for the high renal survival rate reported in our study is the low number of patients that left
the hospital with an impaired renal function, which is, as reported by Stads et al., an important
predictor for progression towards ESRD requiring RRT [38].
Limitations
There are certain limitations to our study that should be taken into consideration before inter-
pretation of the results. First, the single center retrospective design has its inherent drawbacks
and does not offer the possibility to establish causality and it is not known if the results can be
generalized to other ICU populations. Second, the population of patients without comorbidity
was rather small, which results in a lack of statistical power. Third, our study included patients
over a period of 16 years and it is likely that patterns of referral to and treatment in the ICU
have changed over time. Therefore, the year of therapy was included in all multivariable analy-
ses to adjust for possible confounding. Third, it is possible that patients without comorbidity
had chronic renal impairment before hospital admission, which could bias the results of our
study. However, even if some patients with unknown chronic renal impairment were included
it would strengthen our conclusion, because the long-term prognosis in patients without co-
morbidity would be even better. Fourth, it was not possible to collect information on progres-
sive loss of renal function besides progression towards ESRD or renal function at time of
hospital discharge. Thus, it is possible that besides the low number of patients that progressed
towards ESRD there actually was deterioration in renal function. Fifth, besides modality of
CRRT, no further detailed information was available including type of dialysis access, type of
anticoagulation regime, subsequent complications, etc. However, given these limitations, the
results of this study are of interest as the presence or absence of comorbidity seems to have a
substantial effect on the prognosis of the critically ill patient and this study offers an interesting
perspective on such a complex syndrome as AKI.
Conclusions
The results of our study are indicative that the absence of comorbidity in critically ill patients
with RRT-requiring AKI does not have a major impact on hospital mortality but is associated
with a relatively good long-term survival rate and infrequent progression to ESRD. However,
given the aforementioned limitations, future prospective studies with a large sample size are
warranted before firm conclusions can be drawn.
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